A shift towards decentralized, increasing chronic diseases, expanding specialist therapies, healthcare investments, and technological advancements is promoting the market growth.
Redefining Healthcare: The Rise of Outpatient & Home Infusion Services
The outpatient & home infusion services encompass the healthcare services where the patient is offered intravenous or injectable solutions outside the hospital settings. They offer chemotherapies, IV antibiotics, immunotherapies, analgesics, etc. This promotes their use across oncology, infectious diseases, immunology, endocrinology, cardiology, and neurology fields, where they are also used for patient management, hydration therapies, and post-surgical care.
Global Market Growth
The global outpatient & home infusion services market size was estimated at USD 10.78 billion in 2025 and is predicted to increase from USD 11.78 billion in 2026 to approximately USD 26.09 billion by 2035, expanding at a CAGR of 9.24% from 2026 to 2035.
The Road Ahead: Trends Shaping the Outpatient & Home Infusion Services
- The growing chronic disease burden is increasing the demand for outpatient & home infusion services for their long-term management.
- The increasing shift towards home-based care is also increasing the adoption rates.
- Expanding specialty clinics are also promoting their use to deliver advanced biologics or chemotherapy.
- Growing FDA approvals are driving the development of advanced infusion devices as well as drugs, which increases their early adoption.
- Increasing collaborations and reimbursement support are also creating new opportunities for their innovations.
- Growing technological advancements are also driving the development of smart infusion pumps, connected care platforms, and remote monitoring devices.
The graph represents the estimated rates of cancer deaths and new cases in the U.S. in the year 2026. It indicates that there will be a rise in cancer burden, which will drive the shift towards outpatient services and home-based care options. This, in turn, will increase the adoption of outpatient & home infusion services for the effective management and treatment of cancer cases, which will ultimately promote the market growth.
Market Segmentation Overview
- By service type, the home infusion therapy segment accounted for the highest revenue share of 58% share of the U.S. outpatient & home infusion services market in 2025, due to growth in the chronic disease burden. Their affordability and advanced infusion technologies also increased their use. They were also preferred to lower the risk of hospital-acquired infections and enhance patient convenience.
- By disease type, the cancer segment held a major revenue share of 40% of the U.S. outpatient & home infusion services market in 2025, due to growth in the cancer burden and need for long-term IV therapies. This increased the use of outpatient & home infusion services to enhance patient safety and comfort. Their affordability and presence of supportive care drugs also increased their use.
- By product type, the IV infusion sets segment contributed the biggest revenue share of 30% of the U.S. outpatient & home infusion services market in 2025, as they are an essential component for IV therapy. Their affordability, compatibility, and safety standards also increased their use. Their disposable nature also increased their use for a wide range of treatments.
- By end-user, the outpatient centers segment held the largest revenue share of the U.S. outpatient & home infusion services market in 2025, due to growth in the patient volume and presence of advanced infrastructure. Their convenient scheduling and affordable services also increased their use. Insurance coverage and the presence of advanced products also increased their acceptance rates.
Regional Analysis
The U.S. outpatient & home infusion services market held share in 2025 and is expected to show lucrative growth during the forecast period, due to increasing incidences of chronic diseases. The presence of a home infusion ecosystem and advanced healthcare infrastructure also increased their use. Moreover, growth in the shift towards value-based care, increased technological advancements, and development of new therapies also increased their use and innovations, which enhanced the market growth.
The Market Power Players: Top U.S. Companies Driving the Infusion Services
Option Care Health dominated the market with its Comprehensive Chronic Care Service, where Optum Infusion Pharmacy was its closest contender, which provided Payer-Provider Integration. CVS Health also sustained its position by providing Coram CVS Specialty Infusion Services, where Paregon Healthcare also contributed to the market growth with the launch of multiple ambulatory infusion centres.
Segments Covered in the Report
By Service Type
- Home Infusion Therapy
- Parenteral Nutrition
- Antibiotic Therapy
- Chemotherapy
- Pain Management
- Immunoglobulin Therapy
- Outpatient Infusion Therapy
- Chemotherapy Infusion
- Immunotherapy
- Biologic Infusion
- Pain Management
- Hydration Therapy
By Disease Type
- Cancer
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Others
- Autoimmune Diseases
- Rheumatoid Arthritis
- Crohn's Disease
- Multiple Sclerosis
- Psoriasis
- Infectious Diseases
- Bacterial Infections
- HIV/AIDS
- Hepatitis
- Tuberculosis
- Pain Management
- Chronic Pain
- Acute Pain
- Neuropathic Pain
- Others
- Cardiac Conditions
- Endocrine Disorders
- Neurological Diseases
By Product Type
- IV Infusion Sets
- Infusion Pumps
- IV Bags
- Catheters
- Others
By End-User
- Hospitals
- Homecare Providers
- Outpatient Centers
- Specialty Clinics
